Latest Cyclopropanes Stories
NEW YORK, Jan. 5, 2015 /PRNewswire/ -- Exelixis, Inc. (NASDAQ: EXEL) is a biotechnology company that develops and markets treatments for cancer.
LONDON and PITTSBURGH, Dec. 4, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S.
PITTSBURGH and LONDON, Dec. 4, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S.
WHIPPANY, N.J., Nov. 24, 2014 /PRNewswire/ -- The U.S.
This innovative combination of drugs could become the treatment of choice in those cases BARCELONA, Spain, September 29, 2014 /PRNewswire/ -- Laboratorios SALVAT
DALLAS, September 7, 2014 /PRNewswire/ -- MarketOptimizer.org adds "Acute Coronary Syndrome - US Drug Forecast and Market Analysis to 2023", a new research report to its
LifeScienceIndustryResearch.com adds Latest Report on “Market Research Report on Global and Chinese Ciprofloxacin HCl Industry, 2009-2019” to its store.
Multimedia assets associated with the below announcement are now available. Assets include: b-roll footage, corporate sound bites, product images and additional information.
The DrugNews Center is the web’s largest source for prescription drug warnings, research and legal news.
- A poem in which the author retracts something said in an earlier poem.